Alcidion Group (ALC) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved record FY25 revenue of $40.8M, with 63% from the UK and 37% from ANZ, driven by new customer wins and expansion in key markets.
New total contract value (TCV) of $73.8M, up 109% year-over-year, driven by a $39M+ EPR contract.
Underlying EBITDA reached $5.1M, with positive operating cashflow of $5.8M, reversing prior year losses.
Strengthened leadership team, especially in the UK and Australia, to support growth and market expansion.
FY26 starts with $34M in contracted revenue, providing strong momentum for continued growth.
Financial highlights
FY25 revenue grew 10% year-over-year to $40.8M, with ARR at $28.5M, up 31%.
New and renewal TCV rose 109% to $73.8M, more than doubling the prior year.
Delivered maiden net profit after tax of $1.7M, a $10.1M improvement year-over-year.
Underlying EBITDA improved from a $3.4M loss in FY24 to $5.1M profit in FY25.
Gross margin increased to over 88%, with operating costs down 10%.
Outlook and guidance
Entered FY26 with contracted and renewal revenue of $34M, the highest ever, expected to grow with new wins.
Targeting positive EBITDA and operating cashflow for FY26; growth depends on timing of new contracts.
Growth strategy focuses on scaling core products in existing markets and exploring new geographies such as Canada, Saudi Arabia, and UAE.
Ongoing review of M&A opportunities that are strategic and synergistic.
Latest events from Alcidion Group
- Record revenue and EBITDA growth, driven by major contract wins and strong UK/ANZ performance.ALC
H1 202626 Feb 2026 - Major EPR contract wins and record cash flow drive robust FY24 results despite procurement delays.ALC
Q4 20242 Feb 2026 - Recurring revenue up to 74%, cost cuts drive improved H2 EBITDA and positive cash flow.ALC
H2 202423 Jan 2026 - Recurring revenue growth, cost savings, and new contracts support FY2025 profitability outlook.ALC
AGM 202419 Jan 2026 - Q1 FY25 saw $5.2M new sales, strong recurring revenue, and improved cash flow.ALC
Q1 202517 Jan 2026 - Q2 FY26 saw strong sales, 40% revenue growth, and a robust cash position with no debt.ALC
Q2 202615 Jan 2026 - Strong Q2 with major new contracts, robust recurring revenue, and positive full-year outlook.ALC
Q2 20259 Jan 2026 - Record new contracts and positive EBITDA drive a strong FY25 outlook despite lower revenue.ALC
H1 202524 Dec 2025 - Record Q3 cashflow and major UK contracts drive upgraded FY2025 EBITDA outlook.ALC
Q3 202528 Nov 2025